down arrow

Beijing Hotgen Biotech Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003P82
  • SHG: 688068
CNY
95.46
-1.19 (-1.23%)

Sep 23

SHG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Beijing Hotgen Biotech Co., Ltd.

Why is Beijing Hotgen Biotech Co., Ltd. ?

1
Poor Management Efficiency with a low ROCE of 40.14%
  • The company has been able to generate a Return on Capital Employed (avg) of 40.14% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
  • Poor long term growth as Net Sales has grown by an annual rate of -24.14% and Operating profit at -184.59% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 25.58% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -24.14% and Operating profit at -184.59% over the last 5 years
4
The company has declared Negative results for the last 17 consecutive quarters
  • NET PROFIT(HY) At CNY -110.88 MM has Grown at -208.73%
  • OPERATING CASH FLOW(Y) Lowest at CNY -178.43 MM
  • ROCE(HY) Lowest at -9.6%
5
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -46.85%, its profits have fallen by -41.1%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Beijing Hotgen Biotech Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Beijing Hotgen Biotech Co., Ltd.
-46.77%
3.45
70.44%
China Shanghai Composite
3.0%
0.22
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-24.14%
EBIT Growth (5y)
-184.59%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.16
Tax Ratio
2.91%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
32.11%
ROE (avg)
25.58%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.86
EV to EBIT
-16.25
EV to EBITDA
-19.95
EV to Capital Employed
4.67
EV to Sales
13.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-28.73%
ROE (Latest)
-11.89%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
NET PROFIT(HY)

Higher at CNY -110.88 MM

RAW MATERIAL COST(Y)

Fallen by -25.54% (YoY

NET SALES(Q)

Highest at CNY 151.72 MM

-21What is not working for the Company
NET PROFIT(HY)

At CNY -110.88 MM has Grown at -208.73%

OPERATING CASH FLOW(Y)

Lowest at CNY -178.43 MM

ROCE(HY)

Lowest at -9.6%

INTEREST(Q)

At CNY 7.63 MM has Grown at inf%

Here's what is working for Beijing Hotgen Biotech Co., Ltd.

Net Sales
At CNY 151.72 MM has Grown at 42.06%
over average net sales of the previous four periods of CNY 106.8 MM
MOJO Watch
Near term sales trend is very positive

Net Sales (CNY MM)

Net Profit
Higher at CNY -110.88 MM
than preceding 12 month period ended Jun 2026
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Net Sales
Highest at CNY 151.72 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Raw Material Cost
Fallen by -25.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Beijing Hotgen Biotech Co., Ltd.

Net Profit
At CNY -110.88 MM has Grown at -208.73%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow
Lowest at CNY -178.43 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest
At CNY 7.63 MM has Grown at inf%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Footer loading